Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine

John M. Andersen, Kathryn S. Sugerman, Jennifer R. Lockhart, Warren A. Weinberg

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Objective. To evaluate our experience using the antimigraine prophylactic drugs, amitriptyline and cyproheptadine, for the prophylactic management of cyclic vomiting syndrome (CVS) in children. Methods and Patients. Twenty-seven patients (16 males) ranging in age from 2 to 16 years at diagnosis, fulfilling the diagnostic criteria for CVS and treated prophylactically with either amitriptyline (22) or/and cyproheptadine (6) were identified through retrospective chart review. Individual patient data were corroborated by the attending physician and/or interviews with patients and families. Minimum follow-up time before entry into the study group was 5 months. Patients were stratified according to three treatment outcomes: 1) complete response-no attacks, 2) partial response-50% or greater reduction in frequency of attacks, and 3) no response-less than 50% decrease in frequency of attacks. Results. Of the 22 patients treated with amitriptyline, 16 (73%) had a complete response while 4 (18%) had a partial response. Of the 6 patients treated with cyproheptadine, 4 (66%) had a complete response and 1 (17%) had a partial response. Thus, 91% of the amitriptyline group and 83% of the cyproheptadine group had at least a partial response to therapy. No patients experienced significant side effects to either medication. Conclusion. The antimigraine prophylactic drugs, amitriptyline and cyproheptadine, represent effective prophylactic agents for the management of CVS in the vast majority of patients fulfilling the diagnostic criteria for this syndrome.

Original languageEnglish (US)
Pages (from-to)977-981
Number of pages5
JournalPediatrics
Volume100
Issue number6
StatePublished - Dec 1997

Fingerprint

Cyproheptadine
Amitriptyline
Therapeutics
Familial cyclic vomiting syndrome
Pharmaceutical Preparations
Interviews
Physicians

Keywords

  • Amitriptyline
  • Cyclic vomiting syndrome
  • Cyproheptadine
  • Migraine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. / Andersen, John M.; Sugerman, Kathryn S.; Lockhart, Jennifer R.; Weinberg, Warren A.

In: Pediatrics, Vol. 100, No. 6, 12.1997, p. 977-981.

Research output: Contribution to journalArticle

Andersen, John M. ; Sugerman, Kathryn S. ; Lockhart, Jennifer R. ; Weinberg, Warren A. / Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. In: Pediatrics. 1997 ; Vol. 100, No. 6. pp. 977-981.
@article{52dd36badaf448d0afb869157a8435e4,
title = "Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine",
abstract = "Objective. To evaluate our experience using the antimigraine prophylactic drugs, amitriptyline and cyproheptadine, for the prophylactic management of cyclic vomiting syndrome (CVS) in children. Methods and Patients. Twenty-seven patients (16 males) ranging in age from 2 to 16 years at diagnosis, fulfilling the diagnostic criteria for CVS and treated prophylactically with either amitriptyline (22) or/and cyproheptadine (6) were identified through retrospective chart review. Individual patient data were corroborated by the attending physician and/or interviews with patients and families. Minimum follow-up time before entry into the study group was 5 months. Patients were stratified according to three treatment outcomes: 1) complete response-no attacks, 2) partial response-50{\%} or greater reduction in frequency of attacks, and 3) no response-less than 50{\%} decrease in frequency of attacks. Results. Of the 22 patients treated with amitriptyline, 16 (73{\%}) had a complete response while 4 (18{\%}) had a partial response. Of the 6 patients treated with cyproheptadine, 4 (66{\%}) had a complete response and 1 (17{\%}) had a partial response. Thus, 91{\%} of the amitriptyline group and 83{\%} of the cyproheptadine group had at least a partial response to therapy. No patients experienced significant side effects to either medication. Conclusion. The antimigraine prophylactic drugs, amitriptyline and cyproheptadine, represent effective prophylactic agents for the management of CVS in the vast majority of patients fulfilling the diagnostic criteria for this syndrome.",
keywords = "Amitriptyline, Cyclic vomiting syndrome, Cyproheptadine, Migraine",
author = "Andersen, {John M.} and Sugerman, {Kathryn S.} and Lockhart, {Jennifer R.} and Weinberg, {Warren A.}",
year = "1997",
month = "12",
language = "English (US)",
volume = "100",
pages = "977--981",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "6",

}

TY - JOUR

T1 - Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine

AU - Andersen, John M.

AU - Sugerman, Kathryn S.

AU - Lockhart, Jennifer R.

AU - Weinberg, Warren A.

PY - 1997/12

Y1 - 1997/12

N2 - Objective. To evaluate our experience using the antimigraine prophylactic drugs, amitriptyline and cyproheptadine, for the prophylactic management of cyclic vomiting syndrome (CVS) in children. Methods and Patients. Twenty-seven patients (16 males) ranging in age from 2 to 16 years at diagnosis, fulfilling the diagnostic criteria for CVS and treated prophylactically with either amitriptyline (22) or/and cyproheptadine (6) were identified through retrospective chart review. Individual patient data were corroborated by the attending physician and/or interviews with patients and families. Minimum follow-up time before entry into the study group was 5 months. Patients were stratified according to three treatment outcomes: 1) complete response-no attacks, 2) partial response-50% or greater reduction in frequency of attacks, and 3) no response-less than 50% decrease in frequency of attacks. Results. Of the 22 patients treated with amitriptyline, 16 (73%) had a complete response while 4 (18%) had a partial response. Of the 6 patients treated with cyproheptadine, 4 (66%) had a complete response and 1 (17%) had a partial response. Thus, 91% of the amitriptyline group and 83% of the cyproheptadine group had at least a partial response to therapy. No patients experienced significant side effects to either medication. Conclusion. The antimigraine prophylactic drugs, amitriptyline and cyproheptadine, represent effective prophylactic agents for the management of CVS in the vast majority of patients fulfilling the diagnostic criteria for this syndrome.

AB - Objective. To evaluate our experience using the antimigraine prophylactic drugs, amitriptyline and cyproheptadine, for the prophylactic management of cyclic vomiting syndrome (CVS) in children. Methods and Patients. Twenty-seven patients (16 males) ranging in age from 2 to 16 years at diagnosis, fulfilling the diagnostic criteria for CVS and treated prophylactically with either amitriptyline (22) or/and cyproheptadine (6) were identified through retrospective chart review. Individual patient data were corroborated by the attending physician and/or interviews with patients and families. Minimum follow-up time before entry into the study group was 5 months. Patients were stratified according to three treatment outcomes: 1) complete response-no attacks, 2) partial response-50% or greater reduction in frequency of attacks, and 3) no response-less than 50% decrease in frequency of attacks. Results. Of the 22 patients treated with amitriptyline, 16 (73%) had a complete response while 4 (18%) had a partial response. Of the 6 patients treated with cyproheptadine, 4 (66%) had a complete response and 1 (17%) had a partial response. Thus, 91% of the amitriptyline group and 83% of the cyproheptadine group had at least a partial response to therapy. No patients experienced significant side effects to either medication. Conclusion. The antimigraine prophylactic drugs, amitriptyline and cyproheptadine, represent effective prophylactic agents for the management of CVS in the vast majority of patients fulfilling the diagnostic criteria for this syndrome.

KW - Amitriptyline

KW - Cyclic vomiting syndrome

KW - Cyproheptadine

KW - Migraine

UR - http://www.scopus.com/inward/record.url?scp=0030686407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030686407&partnerID=8YFLogxK

M3 - Article

C2 - 9374568

AN - SCOPUS:0030686407

VL - 100

SP - 977

EP - 981

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 6

ER -